Wing-Ming Chu

The University of Hong Kong - Division of Infectious Disease

SCHOLARLY PAPERS

4

DOWNLOADS

381

TOTAL CITATIONS

1

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Comparative Efficacy of Combination Treatment with Nirmatrelvir-Ritonavir and Remdesivir Versus Remdesivir Monotherapy in Hospitalised COVID-19 Patients: A Target Trial Emulation Study

Number of pages: 47 Posted: 08 Jan 2024
Ming Hong Choi, Eric Yuk Fai Wan, Ian Chi Kei Wong, Esther W. Chan, Anthony Raymond Tam, Wing-Ming Chu and Ivan Fan Ngai Hung
The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - Centre for Safe Medication Practice and Research, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Division of Infectious Disease and The University of Hong Kong - School of Clinical Medicine
Downloads 123 (494,143)
Citation 1

Abstract:

Loading...

SARS-CoV-2, COVID-19, nirmatrelvir-ritonavir, remdesivir, combination therapy, Hong Kong

2.

Safety and Efficacy of Nirmatrelvir/Ritonavir in Advanced Kidney Disease

Number of pages: 32 Posted: 05 Jul 2023
Wing-Ming Chu, Chun-Ka WONG, Ting Fung Ma, Ali Choo, Anthony Raymond Tam, Hung-Fat Tse Tse and Ivan Fan Ngai Hung
The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - School of Clinical Medicine, University of South Carolina - Department of Statistics, The University of Hong Kong - School of Clinical Medicine, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Cardiology Division and The University of Hong Kong - School of Clinical Medicine
Downloads 121 (500,474)

Abstract:

Loading...

COVID-19, SARS-CoV-2, nirmatrelvir/ritonavir, paxlovid, molnupiravir, chronic kidney disease, CKD, end-stage kidney disease, renal impairment, dialysis, hemodialysis, peritoneal dialysis

3.

Immune Imprinting with Ancestral SARS-CoV-2 Strain Induced Potent Neutralizing Activity Against Omicron Sublineages BA.2, BA.2.12.1 and BA.4/5

Number of pages: 24 Posted: 01 Sep 2022
Xiaojuan Zhang, Lin-Lei Chen, Syed Muhammad Umer Abdullah, Jian-Piao Cai, Anthony Raymond Tam, Wing-Ming Chu, Wan-Mui Chan, Jonathan Daniel Ip, Allen Wing-Ho Chu, Lu Lu, Brain Pui-Chun Chan, Yan Zhao, Kwok-Hung Chan, Kwok-Yung Yuen, Vincent Chi-Chung Cheng, Ivan Fan Ngai Hung and Kelvin Kai-Wang To
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 109 (541,321)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Omicron variant, BA.2.12.1, BA.4, BA.5 sublineages, immune imprinting, vaccine, neutralizing antibody, hybrid immunity

4.

The Impact of Vaccine Type and Booster Dose on the Magnitude and Breadth of Sars-Cov-2-Specific Mucosal Iga

Number of pages: 28 Posted: 15 May 2024
Hoi-Wah Tsoi, Miko Ka-Wai Ng, Jian-Piao Cai, Rosana Wing-Shan Poon, Brian Pui-Chun Chan, Kwok-Hung Chan, Anthony Raymond Tam, Wing-Ming Chu, Ivan Fan Ngai Hung and Kelvin Kai-Wang To
The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, Government of the Hong Kong Special Administrative Region - Hospital Authority, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - Division of Infectious Disease, The University of Hong Kong - School of Clinical Medicine and The University of Hong Kong - State Key Laboratory of Emerging Infectious Diseases
Downloads 28 (1,058,502)

Abstract:

Loading...

COVID-19 vaccine, SARS-CoV-2, Omicron variant, mucosal immunity, saliva, IgA